Dose-response Associations of Cardiorespiratory Fitness with All-cause Mortality and Incidence and Mortality of Cancer and Cardiovascular and Respiratory Diseases: the UK Biobank Cohort Study
Overview
Authors
Affiliations
Objective: To investigate the association of cardiorespiratory fitness with all-cause mortality, and cardiovascular disease (CVD), respiratory disease, chronic obstructive pulmonary disease (COPD) and cancer mortality and incidence.
Design: Prospective population-based study.
Setting: UK Biobank.
Participants: Of the 5 02 628 (5.5% response rate) participants recruited by UK Biobank, we included 73 259 (14.6%) participants with available data in this analysis. Of these, 1374 participants died and 4210 developed circulatory diseases, 1293 respiratory diseases and 4281 cancer, over a median of 5.0 years (IQR 4.3-5.7) follow-up.
Main Outcome Measures: All-cause mortality and circulatory disease, respiratory disease, COPD and cancer (such as colorectal, lung, breast and prostate) mortality/incidence. Fitness was estimated using a submaximal cycle ergometer test.
Results: The HR for all-cause mortality for each metabolic equivalent of task (MET) higher fitness was 0.96 (95% CI 0.93 to 0.98). Similar results were observed for incident circulatory disease (HR 0.96 [0.95 to 0.97]), respiratory disease (HR 0.96 [0.94 to 0.98]), COPD (HR 0.90 [0.86 to 0.95) and colorectal cancer (HR 0.96 [0.92 to 1.00]). Nonlinear analysis revealed that a high level of fitness (>10METs) was associated with a greater incidence of atrial fibrillation (HR 1.24 [1.07 to 1.44]) and prostate cancer (HR 1.16 [1.02 to 1.32]) compared with average fitness. All results were adjusted for sociodemographic, lifestyle and dietary factors, body composition, and morbidity at baseline and excluded events in the first 2 years of follow-up.
Conclusions: Higher cardiorespiratory fitness was associated with lower risk of premature mortality and incidence of CVD, respiratory disease and colorectal cancer.
Reyes-Molina D, Zapata-Lamana R, Nazar G, Cigarroa I, Ruiz J, Parrado E Scand J Med Sci Sports. 2025; 35(1):e70015.
PMID: 39831442 PMC: 11744493. DOI: 10.1111/sms.70015.
Dostal T, Dankova M, Barot T, Sindler D, Kutac P, Jandackova V PLoS One. 2024; 19(12):e0315767.
PMID: 39715184 PMC: 11666063. DOI: 10.1371/journal.pone.0315767.
From Atherosclerotic Plaque to Myocardial Infarction-The Leading Cause of Coronary Artery Occlusion.
Mlynarska E, Czarnik W, Fularski P, Hajdys J, Majchrowicz G, Stabrawa M Int J Mol Sci. 2024; 25(13).
PMID: 39000400 PMC: 11242737. DOI: 10.3390/ijms25137295.
Yang H, Chang Q, Ji C, Zheng G, Ma Z, Chen L Int J Behav Nutr Phys Act. 2024; 21(1):66.
PMID: 38956566 PMC: 11221134. DOI: 10.1186/s12966-024-01617-3.
Pandey A, Willis B, Barlow C, Leonard D, Agusala V, DeFina L JACC Adv. 2024; 1(2):100040.
PMID: 38939318 PMC: 11198193. DOI: 10.1016/j.jacadv.2022.100040.